跳至主要内容
临床试验/NCT03409640
NCT03409640已完成不适用

The Rate of Symptomatic and Asymptomatic Non-malignant, Non-infective Soft Tissue Masses in Primary Metal on Metal Hip Replacement.

Zimmer Biomet1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年1月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Zimmer Biomet
入组人数
100
试验地点
1
主要终点
MRI Scoring change in soft tissue mass size

研究概览

简要总结

This study is being conducted to determine the rate of symptomatic and asymptomatic nonmalignant, noninfective soft tissue mass presence (referred to in the literature as pseudotumour, ALVAL, ARMD, cysts or lesions) in primary metal on metal hip replacement patients. The primary objective of the study is to determine the prevalence of masses in unbiased Metal on Metal (MoM) samples drawn from one study centre. The subjects receiving the Metal on Metal devices will be observed at two specific time points. Secondary objectives are to evaluate whether the occurrence of masses is related to any of several potential factors including patient and implant characteristics and time since the implant procedure took place.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients implanted with the M2a Magnum who were evaluated via MRI and metal ion analysis between 2012 and 2013.

排除标准

  • If the primary device was implanted for less than 36 months (in the case of patients already revised) or has been in place for less than 36 months (in the case of patients with the device still in place).
  • If the patient is contraindicated for any of the diagnostic tests.
  • If the patient fails to consent to participating in the study.

结局指标

主要结局

MRI Scoring change in soft tissue mass size

时间窗: 36 months after primary device implantation

MRI Score - monitor number and size of soft tissue lesions

次要结局

  • Radiographic assessment(36 months after primary device implantation)
  • Oxford Hip Score(36 months after primary device implantation)
  • UCLA Activity Score(36 months after primary device implantation)
  • EQ-5D(36 months after primary device implantation)
  • Metal Ion Levels(36 months after primary device implantation)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验